[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @InvestorSince21 TheIntelligentInvestor TheIntelligentInvestor posts on X about $nvo, xpev, $xpev, xpeng the most. They currently have XXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::1520033393806913536/interactions)  - X Week XXXXX -XXXX% - X Month XXXXXX -XX% - X Year XXXXXXX +2,220,867% ### Mentions: XX [#](/creator/twitter::1520033393806913536/posts_active)  - X Week XX +25% - X Month XX +171% - X Year XXX +17,900% ### Followers: XXX [#](/creator/twitter::1520033393806913536/followers)  - X Week XXX +2.60% - X Month XXX +9.60% - X Year XXX +112% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1520033393806913536/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) XXXX% [automotive brands](/list/automotive-brands) XXXXX% [finance](/list/finance) XXXX% [technology brands](/list/technology-brands) XXXX% [currencies](/list/currencies) XXXX% **Social topic influence** [$nvo](/topic/$nvo) #13, [xpev](/topic/xpev) #23, [$xpev](/topic/$xpev) #23, [xpeng](/topic/xpeng) #84, [$oscr](/topic/$oscr) 6.25%, [$unh](/topic/$unh) 6.25%, [health](/topic/health) 6.25%, [stocks](/topic/stocks) 6.25%, [titan](/topic/titan) 3.13%, [$150b](/topic/$150b) XXXX% **Top accounts mentioned or mentioned by** [@elixabliss](/creator/undefined) [@jumpdoodlebob](/creator/undefined) [@theronnievshow](/creator/undefined) [@fsctrades](/creator/undefined) **Top assets mentioned** [Novo-Nordisk (NVO)](/topic/$nvo) [XPeng Inc. (XPEV)](/topic/$xpev) [Oscar Health, Inc. (OSCR)](/topic/$oscr) [UnitedHealth Group (UNH)](/topic/$unh) [Hertz Global Holdings, Inc Common Stock (HTZ)](/topic/hertz) [Hertz Network (HTZ)](/topic/$htz) [Goldman Sachs (GS)](/topic/goldman-sachs) [GammaSwap (GS)](/topic/$gs) ### Top Social Posts Top posts by engagements in the last XX hours "Excited about $NVO Novo Nordisk is a pharma titan revolutionizing diabetes and obesity care with GLP-1 juggernauts like Ozempic and Wegovy backed by ironclad fundamentals in a $150B+ market. Despite short-term noise long-term growth is locked in. This undervalued powerhouse is set for a massive rebound. A thread: 1/10" [X Link](https://x.com/InvestorSince21/status/1998022038947012681) 2025-12-08T13:29Z XXX followers, XXX engagements "Hertz Global Holdings $HTZ isn't what you'd call a beautiful chart for Elliott Wave analysis. Still I charted it because @elixabliss and @jumpdoodlebob asked for it. It appears to be in primary wave III after completing primary wave II. Next the main moving averages (50/200-day and 50/200-hour) should be tested. If they convert to support the scenario remains active (an interesting level for buyers). If price rejects there a new low becomes probable" [X Link](https://x.com/InvestorSince21/status/1994164346113462665) 2025-11-27T22:00Z XXX followers, XXX engagements "Which stock should I chart next $UNH $NVO $OSCR or $XPEV Drop other suggestions in the comments" [X Link](https://x.com/InvestorSince21/status/1996824541969240248) 2025-12-05T06:10Z XXX followers, XXX engagements "I just love the design of the XPeng P7 $XPEV" [X Link](https://x.com/InvestorSince21/status/1996964147657855385) 2025-12-05T15:25Z XXX followers, XXX engagements "About which company should the next fundamental thread be $NVO $UNH $XPEV or $JD" [X Link](https://x.com/InvestorSince21/status/1997441308877623610) 2025-12-06T23:01Z XXX followers, XXX engagements "@TheRonnieVShow $OSCR is also my largest holding but my second is $XPEV" [X Link](https://x.com/InvestorSince21/status/1997717270358000047) 2025-12-07T17:18Z XXX followers, XXX engagements "First $NVO isn't just riding a trend; it's leading a healthcare revolution. Founded over a century ago it's now the king of GLP-1 drugs capturing XX% market share internationally. Q3 revenues hit DKK 75B (up X% YoY) with 9-month sales soaring XX% to fuel 46M patients worldwide. In a trillion-dollar chronic disease TAM X% penetration means epic runway while revenues could triple with modest share gains #NVO 2/10" [X Link](https://x.com/InvestorSince21/status/1998022042369642586) 2025-12-08T13:29Z XXX followers, XXX engagements "Analysts are all-in: Consensus "Buy" rating with $54-62 PTs implying 15-30% upside from $XX levels. Seeking Alpha calls it a 'Strong Buy' for undervaluation and wide moat; Goldman Sachs $GS sees long-term obesity dominance despite noise. Even bears admit the sell-off disconnected from fundamentals. The path to profitability and EPS growth (6.9% annually) remains intact. Bullish chorus 5/10" [X Link](https://x.com/InvestorSince21/status/1998022053513801956) 2025-12-08T13:29Z XXX followers, XX engagements "Valuation Absolute steal. Trading at 12-13x forward P/E (near 10-year lows) despite XX% 3-year revenue CAGR and 45%+ operating margins. P/S at 4.4x P/B 8xall screaming value vs. peers. Undervalued by XX% per models with XXX% dividend yield as cherry on top. Revenues doubled since 2020 yet stock's at those levels Bargain hunter's dream 6/10" [X Link](https://x.com/InvestorSince21/status/1998022057188110744) 2025-12-08T13:29Z XXX followers, XX engagements "Technicals flashing green: Oversold RSI reclaiming key supports near $XX with volume spikes on earnings. Shorts covering as sentiment flips. This isn't a fade; it's the floor for a multi-year uptrend in healthcare. 8/10" [X Link](https://x.com/InvestorSince21/status/1998022064071139646) 2025-12-08T13:29Z XXX followers, XX engagements "Bottom line: $NVO's at an inflection with unbeatable fundamentalsrobust growth fortress balance sheet and leadership in life-changing meds. Priced for doom but built to soar in a desperate-for-innovation sector. I'm stacking shares for the long run 🚀 #PharmaStocks #Investing 9/10" [X Link](https://x.com/InvestorSince21/status/1998022067606716835) 2025-12-08T13:29Z XXX followers, XXX engagements "I personally do not like the cars BYD builds so I do not invest in it. I like $XPEV and $NIO similarly but my $XPEV position is currently up around XXX% while my $NIO position is only slightly up. As a result my position in XPeng is now larger. The initial investment was the same in both" [X Link](https://x.com/InvestorSince21/status/1998054865189175792) 2025-12-08T15:39Z XXX followers, XX engagements "Wave X may be finished for Novo Nordisk $NVO Price rose to the 200-hour MA and rejected with a second test and rejection. I expect a corrective pullback before the MA flips to support. The 0.50.618 Fibonacci zone is a suitable buy entry. Think about its fundamentals" [X Link](https://x.com/InvestorSince21/status/1997077484001476662) 2025-12-05T22:55Z XXX followers, 2461 engagements "Exactly as expected Novo Nordisk $NVO dropped into the 0.5-0.618 Fibonacci range and is currently at the XXX Fib. The next challenge is to convert the 50- and 200-hour MAs into support. Once that happens nothing stands in the way of wave X which should take it to the XXXXX Fibonacci at $56.78" [X Link](https://x.com/InvestorSince21/status/1998460612423082092) 2025-12-09T18:31Z XXX followers, 1626 engagements "From viral catwalks to real-world deployment: XPeng's Next-Gen IRON humanoid redefines anthropomorphic design with flexible spines and customizable forms. As EV sales volumes surge this innovation unlocks new revenue streams in guidance and salespositioning $XPEV for 10x potential" [X Link](https://x.com/InvestorSince21/status/1998499301333590059) 2025-12-09T21:05Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@InvestorSince21 TheIntelligentInvestor
TheIntelligentInvestor posts on X about $nvo, xpev, $xpev, xpeng the most. They currently have XXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXX -XXXX%
- X Month XXXXXX -XX%
- X Year XXXXXXX +2,220,867%
Mentions: XX #
- X Week XX +25%
- X Month XX +171%
- X Year XXX +17,900%
Followers: XXX #
- X Week XXX +2.60%
- X Month XXX +9.60%
- X Year XXX +112%
CreatorRank: XXXXXXXXX #
Social Influence
Social category influence stocks XXXX% automotive brands XXXXX% finance XXXX% technology brands XXXX% currencies XXXX%
Social topic influence $nvo #13, xpev #23, $xpev #23, xpeng #84, $oscr 6.25%, $unh 6.25%, health 6.25%, stocks 6.25%, titan 3.13%, $150b XXXX%
Top accounts mentioned or mentioned by @elixabliss @jumpdoodlebob @theronnievshow @fsctrades
Top assets mentioned Novo-Nordisk (NVO) XPeng Inc. (XPEV) Oscar Health, Inc. (OSCR) UnitedHealth Group (UNH) Hertz Global Holdings, Inc Common Stock (HTZ) Hertz Network (HTZ) Goldman Sachs (GS) GammaSwap (GS)
Top Social Posts
Top posts by engagements in the last XX hours
"Excited about $NVO Novo Nordisk is a pharma titan revolutionizing diabetes and obesity care with GLP-1 juggernauts like Ozempic and Wegovy backed by ironclad fundamentals in a $150B+ market. Despite short-term noise long-term growth is locked in. This undervalued powerhouse is set for a massive rebound. A thread: 1/10"
X Link 2025-12-08T13:29Z XXX followers, XXX engagements
"Hertz Global Holdings $HTZ isn't what you'd call a beautiful chart for Elliott Wave analysis. Still I charted it because @elixabliss and @jumpdoodlebob asked for it. It appears to be in primary wave III after completing primary wave II. Next the main moving averages (50/200-day and 50/200-hour) should be tested. If they convert to support the scenario remains active (an interesting level for buyers). If price rejects there a new low becomes probable"
X Link 2025-11-27T22:00Z XXX followers, XXX engagements
"Which stock should I chart next $UNH $NVO $OSCR or $XPEV Drop other suggestions in the comments"
X Link 2025-12-05T06:10Z XXX followers, XXX engagements
"I just love the design of the XPeng P7 $XPEV"
X Link 2025-12-05T15:25Z XXX followers, XXX engagements
"About which company should the next fundamental thread be $NVO $UNH $XPEV or $JD"
X Link 2025-12-06T23:01Z XXX followers, XXX engagements
"@TheRonnieVShow $OSCR is also my largest holding but my second is $XPEV"
X Link 2025-12-07T17:18Z XXX followers, XXX engagements
"First $NVO isn't just riding a trend; it's leading a healthcare revolution. Founded over a century ago it's now the king of GLP-1 drugs capturing XX% market share internationally. Q3 revenues hit DKK 75B (up X% YoY) with 9-month sales soaring XX% to fuel 46M patients worldwide. In a trillion-dollar chronic disease TAM X% penetration means epic runway while revenues could triple with modest share gains #NVO 2/10"
X Link 2025-12-08T13:29Z XXX followers, XXX engagements
"Analysts are all-in: Consensus "Buy" rating with $54-62 PTs implying 15-30% upside from $XX levels. Seeking Alpha calls it a 'Strong Buy' for undervaluation and wide moat; Goldman Sachs $GS sees long-term obesity dominance despite noise. Even bears admit the sell-off disconnected from fundamentals. The path to profitability and EPS growth (6.9% annually) remains intact. Bullish chorus 5/10"
X Link 2025-12-08T13:29Z XXX followers, XX engagements
"Valuation Absolute steal. Trading at 12-13x forward P/E (near 10-year lows) despite XX% 3-year revenue CAGR and 45%+ operating margins. P/S at 4.4x P/B 8xall screaming value vs. peers. Undervalued by XX% per models with XXX% dividend yield as cherry on top. Revenues doubled since 2020 yet stock's at those levels Bargain hunter's dream 6/10"
X Link 2025-12-08T13:29Z XXX followers, XX engagements
"Technicals flashing green: Oversold RSI reclaiming key supports near $XX with volume spikes on earnings. Shorts covering as sentiment flips. This isn't a fade; it's the floor for a multi-year uptrend in healthcare. 8/10"
X Link 2025-12-08T13:29Z XXX followers, XX engagements
"Bottom line: $NVO's at an inflection with unbeatable fundamentalsrobust growth fortress balance sheet and leadership in life-changing meds. Priced for doom but built to soar in a desperate-for-innovation sector. I'm stacking shares for the long run 🚀 #PharmaStocks #Investing 9/10"
X Link 2025-12-08T13:29Z XXX followers, XXX engagements
"I personally do not like the cars BYD builds so I do not invest in it. I like $XPEV and $NIO similarly but my $XPEV position is currently up around XXX% while my $NIO position is only slightly up. As a result my position in XPeng is now larger. The initial investment was the same in both"
X Link 2025-12-08T15:39Z XXX followers, XX engagements
"Wave X may be finished for Novo Nordisk $NVO Price rose to the 200-hour MA and rejected with a second test and rejection. I expect a corrective pullback before the MA flips to support. The 0.50.618 Fibonacci zone is a suitable buy entry. Think about its fundamentals"
X Link 2025-12-05T22:55Z XXX followers, 2461 engagements
"Exactly as expected Novo Nordisk $NVO dropped into the 0.5-0.618 Fibonacci range and is currently at the XXX Fib. The next challenge is to convert the 50- and 200-hour MAs into support. Once that happens nothing stands in the way of wave X which should take it to the XXXXX Fibonacci at $56.78"
X Link 2025-12-09T18:31Z XXX followers, 1626 engagements
"From viral catwalks to real-world deployment: XPeng's Next-Gen IRON humanoid redefines anthropomorphic design with flexible spines and customizable forms. As EV sales volumes surge this innovation unlocks new revenue streams in guidance and salespositioning $XPEV for 10x potential"
X Link 2025-12-09T21:05Z XXX followers, XXX engagements